We live in a time of tremendous turmoil: orchestrated financial collapse, plans for Ebola martial law, nuclear war….Some even claim we are living through the End Times as described in the Book of Revelation.

Join me on my journey to Athens and Patmos and to a bigger perspective on the events of today.

Patmos is the island where John wrote the Book of Revelation. Check out this blog for pictures and posts.

Comments Off on THE BIGGER PERSPECTIVE: JOIN ME ON A JOURNEY TO PATMOS ISLAND, GREECE | Uncategorized | Permalink Posted by Jane Burgermeister

–
The extremely short trial period means there will be no data on the longer term antibody response to the vaccine.

–
Controversial bioweapons researcher Dr. Daniel Bausch, who works for Tulane University and a US Navy medical research centre, called the results promising but admitted there are many challenges to know whether the vaccine is safe and works.
ttp://www.reuters.com/article/2014/11/26/us-health-ebola-vaccine-idUSKCN0JA2A720141126

–
In monkey trials, the GSK/NIH vaccine offered protection with a second booster shot, but GSK has no plans for a booster shot.

–
Phase-one trials in the UK, Switzerland and Mali are also coming to an end, paving the way for the World Health Organization (WHO) and a panel of experts to green light mass vaccinations in West Africa by the end of December.

–GSK claims that the experimental vaccine needs to be tested where Ebola is rife to know whether it works. However, there are significant risks associated with giving an experimental vaccine with potentially dangerous side effects to virtually all the health workers in Ebola affected countries. If the health systems collapse because healthcare workers are infected or made sick by the vaccine, it could pave the way for forced mass vaccinations conducted by the military.

–Merck this week bought the rights to another Ebola vaccine under development byNewLink Genetics for up to $50m in a sign that Big Pharma is ramping up production of the experimental vaccine.

–A third Ebola vaccine is being developed by Johnson & Johnson.

–
GSK said it expected to have up to 20,000 doses ready for trials by the end of the year. It is plans to produce 230,000 Ebola vaccine doses a month by April and up to one million a month by the end of 2015.

–
Donors including the European Commission, the Bill and Melinda Gates Foundation and the Wellcome Trust.

–GSK and other pharmaceutical companies are seeking indemnities and other drugmakers against losses and liabilities should the vaccines dangerous cause side-effects.

Friends and followers:
We are collecting funds to get printed Andrea Santander´s book “MARCA ROJA: Mentiras, Vacunas y Fármacos” (RED MARK: Lies, vaccines & drugs), as her only way is to have a certain amount of money to do it independently.
We have a page on the social funding site: idea.me and we are promoting our project today. They give us only 36 days from now.The link is this: http://idea.me/projects/24986/quotmarca-rojaquotRead the rest of this entry »

Comments Off on PLEASE SUPPORT ANDREA SANTANDER AND THE INDEPENDENT MEDIA – OR CHOSE BETWEEN THE LIES OF INFOWARS AND NY TIMES | Uncategorized | Permalink Posted by Jane Burgermeister

“By 2013, the Public Health Agency, backed by the Department of National Defence, had spent $887,000 to have a German company, IDT Biologika, manufacture 1,500 vials of VSV-EBOV suitable for human trials.
It is this stockpile that is slated for use in trials planned for Europe, Africa, the U.S. and Canada.
In short, he Canadian government not only sold off commercial rights to its Ebola vaccine to a for-profit firm at sale-price rates. It also paid the lion’s share of costs required to test the vaccine for human use.But then everything around this vaccine has been unusual.
It was developed not by some grand government design but because, as Helen Branswell of The Canadian Press has written, scientists attracted to the Winnipeg lab in the early years of the century happened to be interested in and knowledgeable about Ebola.
The vaccine was patented in 2003 and then, according to Attaran, more or less forgotten. Until the Defence Department came though with money a few years later, there was no attempt made to manufacture samples fit for human trials.”

WASHINGTON (AP) — The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, public health officials are girding for the next health disaster.

Now the Obama administration has requested$600 million for the CDC to implement what it calls the Global Health Security Agenda, working with an international coalition to shore up disease detection in high-risk countries and guard against the next contagion.

There’s little doubt there will be a next time. Just in recent years, the world has seen bird flu sicken people in Southeast Asia, the respiratory killer SARS spread from China, the 2009 flu pandemic, growing threats from antibiotic-resistant germs, and SARS’ new cousin in the Middle East named MERS.

If bird flu ever mutates to spread between people, “we better look out. It will make Ebola look like a picnic,” Sen. Tom Harkin, D-Iowa, warned a recent Senate Appropriations Committee as he questioned whether $600 million was enough to do the job.